Stock listing
NASDAQ:ACTU Actuate Therapeutics, Inc. Stock
Home listing (NASDAQ) of Actuate Therapeutics, Inc.
Follow Actuate Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ACTU
$0.35 USD +0.01 (+2.3%)
Close on Nov 3, 2026
- Day range
- $0.338 – $0.374 USDNov 3, 2026
- Volume
- 312,301 sharesNov 3, 2026
- Market cap
- $19.25M USDAt the close on Nov 3, 2026 · price × 55.00M shares outstanding
- 52-week range
- $0.33 – $7.90 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $390,234 USDMedian day 274,600 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ACTU · Home | $0.35 USD | +0.008 (+2.3%) | 312,301 | $0.36 | $0.374 | $0.338 | $0.342 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:ACTU · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.35 | +0.008 | +2.3% | $0.36 | $0.374 | $0.338 | 312,301 | |
| $0.342 | +0.007 | +2.1% | $0.38 | $0.38 | $0.335 | 295,455 | |
| $0.335 | -0.036 | -9.7% | $0.38 | $0.385 | $0.33 | 489,500 | |
| $0.371 | -0.012 | -3.1% | $0.383 | $0.42 | $0.36 | 814,000 | |
| $0.383 | -0.017 | -4.3% | $0.404 | $0.407 | $0.361 | 715,700 | |
| $0.40 | -0.128 | -24.2% | $0.379 | $0.438 | $0.35 | 2,210,500 | |
| $0.528 | +0.053 | +11.2% | $0.507 | $0.60 | $0.475 | 236,200 | |
| $0.475 | -0.041 | -7.9% | $0.53 | $0.556 | $0.45 | 255,200 | |
| $0.516 | -0.046 | -8.2% | $0.57 | $0.60 | $0.47 | 335,000 | |
| $0.562 | -0.054 | -8.8% | $0.598 | $0.638 | $0.56 | 220,400 | |
| $0.616 | +0.017 | +2.8% | $0.593 | $0.662 | $0.546 | 166,700 | |
| $0.599 | -0.006 | -1.0% | $0.661 | $0.71 | $0.52 | 727,300 | |
| $0.605 | +0.105 | +21.0% | $0.493 | $0.64 | $0.47 | 926,200 | |
| $0.50 | +0.066 | +15.2% | $0.457 | $0.55 | $0.433 | 472,100 | |
| $0.434 | -0.032 | -6.9% | $0.48 | $0.49 | $0.41 | 439,400 | |
| $0.466 | -0.178 | -27.6% | $0.66 | $0.66 | $0.438 | 967,700 | |
| $0.644 | +0.034 | +5.6% | $0.60 | $0.68 | $0.60 | 285,900 | |
| $0.61 | -0.069 | -10.2% | $0.641 | $0.68 | $0.61 | 295,000 | |
| $0.679 | -0.045 | -6.2% | $0.682 | $0.724 | $0.621 | 324,500 | |
| $0.724 | -0.088 | -10.8% | $0.643 | $0.724 | $0.615 | 637,900 | |
| $0.812 | -0.063 | -7.2% | $0.89 | $0.89 | $0.76 | 337,700 | |
| $0.875 | +0.056 | +6.8% | $0.85 | $0.926 | $0.801 | 201,900 | |
| $0.819 | -0.07 | -7.9% | $0.93 | $0.95 | $0.80 | 91,900 | |
| $0.889 | +0.109 | +14.0% | $0.798 | $0.96 | $0.765 | 494,100 | |
| $0.78 | +0.094 | +13.7% | $0.71 | $0.83 | $0.69 | 409,600 | |
| $0.686 | -0.05 | -6.8% | $0.738 | $0.748 | $0.683 | 111,000 | |
| $0.736 | +0.056 | +8.2% | $0.685 | $0.738 | $0.604 | 276,900 | |
| $0.68 | +0.06 | +9.7% | $0.65 | $0.75 | $0.64 | 382,800 | |
| $0.62 | -0.112 | -15.3% | $0.75 | $0.75 | $0.61 | 272,500 | |
| $0.732 | -0.075 | -9.3% | $0.80 | $0.869 | $0.72 | 222,000 | |
| $0.807 | -0.10 | -11.0% | $0.90 | $0.93 | $0.80 | 187,200 | |
| $0.907 | -0.074 | -7.5% | $0.987 | $1.02 | $0.89 | 274,500 | |
| $0.981 | -0.014 | -1.4% | $1.00 | $1.03 | $0.96 | 113,100 | |
| $0.995 | -0.002 | -0.2% | $1.04 | $1.05 | $0.963 | 174,500 | |
| $0.997 | +0.013 | +1.3% | $1.00 | $1.05 | $0.94 | 208,800 | |
| $0.984 | -0.046 | -4.5% | $1.04 | $1.06 | $0.98 | 148,400 | |
| $1.03 | -0.04 | -3.7% | $1.08 | $1.09 | $0.99 | 259,000 | |
| $1.07 | -0.08 | -7.0% | $1.15 | $1.23 | $1.03 | 239,600 | |
| $1.15 | -0.11 | -8.7% | $1.25 | $1.28 | $1.13 | 204,400 | |
| $1.26 | -0.11 | -8.0% | $1.38 | $1.40 | $1.26 | 119,800 | |
| $1.37 | -0.11 | -7.4% | $1.46 | $1.48 | $1.33 | 210,000 | |
| $1.48 | +0.11 | +8.0% | $1.45 | $1.73 | $1.33 | 1,322,900 | |
| $1.37 | +0.07 | +5.4% | $1.39 | $1.46 | $1.26 | 474,000 | |
| $1.30 | -0.24 | -15.6% | $1.50 | $1.55 | $1.30 | 332,300 | |
| $1.54 | +0.02 | +1.3% | $1.49 | $1.58 | $1.41 | 129,600 | |
| $1.52 | -0.135 | -8.2% | $1.64 | $1.65 | $1.46 | 274,700 | |
| $1.655 | -0.035 | -2.1% | $1.69 | $1.78 | $1.63 | 231,300 | |
| $1.69 | -0.09 | -5.1% | $1.77 | $1.796 | $1.63 | 366,100 | |
| $1.78 | +0.20 | +12.7% | $1.73 | $1.97 | $1.57 | 3,300,900 | |
| $1.58 | +0.35 | +28.5% | $1.24 | $1.58 | $1.20 | 589,187 | |
| $1.23 | -0.04 | -3.1% | $1.28 | $1.31 | $1.181 | 179,285 | |
| $1.27 | +0.04 | +3.3% | $1.22 | $1.342 | $1.18 | 274,700 | |
| $1.23 | +0.17 | +16.0% | $1.06 | $1.34 | $1.01 | 939,000 | |
| $1.06 | +0.01 | +1.0% | $1.04 | $1.10 | $1.00 | 156,500 | |
| $1.05 | +0.06 | +6.1% | $1.00 | $1.14 | $0.989 | 327,900 | |
| $0.99 | -0.02 | -2.0% | $1.02 | $1.03 | $0.95 | 130,400 | |
| $1.01 | +0.035 | +3.6% | $0.966 | $1.03 | $0.90 | 109,600 | |
| $0.975 | +0.005 | +0.5% | $0.98 | $0.985 | $0.942 | 100,900 | |
| $0.97 | -0.04 | -4.0% | $1.00 | $1.01 | $0.935 | 206,500 | |
| $1.01 | -0.01 | -1.0% | $1.02 | $1.04 | $0.912 | 316,158 | |
| $1.02 | -0.085 | -7.7% | $1.13 | $1.14 | $1.00 | 215,472 | |
| $1.105 | -0.125 | -10.2% | $1.24 | $1.25 | $1.10 | 203,500 | |
| $1.23 | +0.10 | +8.8% | $1.15 | $1.25 | $1.12 | 187,000 | |
| $1.13 | +0.01 | +0.9% | $1.12 | $1.22 | $1.07 | 176,600 | |
| $1.12 | +0.06 | +5.7% | $1.08 | $1.15 | $1.02 | 309,800 | |
| $1.06 | -0.05 | -4.5% | $1.14 | $1.14 | $1.055 | 174,800 |
- Ticker
- NASDAQ:ACTU
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 16 slides
Latest news
Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets
Nov 2, 2026
Closed $0.342 (+2.1%) on Nov 2, 2026
Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering
Oct 27, 2026
Closed $0.40 (-24.2%) on Oct 27, 2026
Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 9, 2026
Closed $1.15 (-8.7%) on Sep 10, 2026
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma
Jun 9, 2026
Closed $2.01 (+10.4%) on Jun 9, 2026
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
Jun 1, 2026
Closed $1.99 (-1.5%) on Jun 1, 2026
Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program
May 11, 2026
Closed $2.98 (-9.8%) on May 11, 2026
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
May 6, 2026
Closed $2.99 (-2.6%) on May 6, 2026
Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Apr 14, 2026
Closed $2.08 (+14.3%) on Apr 14, 2026
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
Mar 9, 2026
Closed $2.95 (+3.0%) on Mar 9, 2026
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
Mar 4, 2026
Closed $3.20 (+4.9%) on Mar 5, 2026
Financings
Public offering of common stock and warrants
Oct 27, 2026
Announced: about US$11M · US$0.71 a share · 1 warrant at US$0.45 for 60 months · Newbridge Securities Corporation
Dealers: Newbridge Securities Corporation (lead)
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (November 2026)
Investor deck · 16 slides · November 2026
Investor Presentation (September 2026)
Investor deck · 17 slides · September 2026
Investor Presentation (May 2026)
Investor deck · 18 slides · May 11, 2026
Investor Presentation (January 2026)
Investor deck · 34 slides · January 2026
Actuate Therapeutics, Inc. on 6ix
- News releases
- 17 in the last 12 months · 43 in all · newest Nov 2, 2026 · oldest 2024
- Decks
- 14 decks · latest November 2026
Where Actuate Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACTU · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ACTU | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Actuate Therapeutics, Inc.